ucsf logo

Annemieke van Zante, MD, PhD

Anatomic Pathology • Cytopathology
Fine Needle Aspiration Biopsy Mission Bay
415-353-7043
Portrait of Annemieke van Zante
Portrait of Annemieke van Zante
ucsf logo

Annemieke van Zante, MD, PhD

Anatomic Pathology • Cytopathology
Fine Needle Aspiration Biopsy Mission Bay
415-353-7043

On this page

About me

Dr. Annemieke van Zante is a pathologist who performs and analyzes fine needle aspiration biopsies (in which a needle is inserted into a lump or other abnormal tissue to take a sample of cells). She has a particular interest in head and neck disease processes, reviewing specimens and providing consultations for head and neck cancer.

In her research, van Zante focuses on certain molecular processes involved in regulating cancer cell proliferation.

Van Zante earned her medical degree and doctorate in the UCSF Medical Scientist Training Program. She completed a residency at UCSF in anatomic pathology, the study of disease both microscopically and by looking at entire bodies and organ systems. She also completed fellowships in surgical pathology and cytopathology, the study of abnormalities within cells, at UCSF.

Education & training

Board certification

  • Cytopathology, American Board of Pathology
  • Anatomic Pathology, American Board of Pathology

Fellowship

  • Cytopathology, UCSF Graduate Medical Education
  • Surgical Pathology, UCSF Graduate Medical Education

Residency

  • Anatomic/Clinical Pathology, UCSF Graduate Medical Education

Degree

  • MD, UCSF School of Medicine

My expertise

  • Specialties
    • Anatomic Pathology
    • Cytopathology

Locations

    Please check with your health insurance plan regarding coverage for this type of care. Not all providers at UCSF Health are covered by every insurance plan.

    For informational purposes only, a link to the federal Centers for Medicare and Medicaid Services (CMS) Open Payments web page is provided here. The federal Physician Payments Sunshine Act requires that detailed information about payment and other payments of value worth over ten dollars ($10) from manufacturers of drugs, medical devices, and biologics to physicians and teaching hospitals be made available to the public.